NCT03885713 Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease Status COMPLETED Phase PHASE4
NCT03884439 Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) Status COMPLETED Phase N/A
NCT03872726 Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT03872271 Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial Status UNKNOWN Phase NA
NCT03869905 Aquamin® as an Adjuvant Intervention for Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03863886 Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis Status UNKNOWN Phase NA
NCT03849599 A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT03843385 Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03839680 Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis Status UNKNOWN Phase N/A
NCT03836612 Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study Status COMPLETED Phase N/A
NCT03832400 Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) Status COMPLETED Phase PHASE1
NCT03824561 Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] Status COMPLETED Phase N/A
NCT03824418 The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis Status COMPLETED Phase N/A
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Status RECRUITING Phase PHASE1
NCT03809728 IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE Status RECRUITING Phase NA